Frontiers | Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective | Pharmacology
κ-opioid receptor - Wikipedia
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists | Pharmacology
Neuropharmacology: Opioids, Anesthetics, Skeletal Muscle Relaxants Flashcards | Quizlet
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Manifestations of acute opiate withdrawal contracture in rabbit jejunum after mu-, kappa- and delta-receptor agonist exposure. - Abstract - Europe PMC
Targeting the Kappa Opioid Receptor to Reduce Drug Use and Relapse | National Institute on Drug Abuse (NIDA)
Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Comparing Lofexidine and Clonidine for Opioid Withdrawal Management
Buprenorphine Education: Technical explanation of Buprenorphine mu receptor, affinity of agonist and antagonist
![PDF] Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b1b46d0e897ae40d7f923341beadb88705c50501/5-Table1-1.png "PDF] Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse | Semantic Scholar")
PDF] Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse | Semantic Scholar
Kappa Opiate Receptor - an overview | ScienceDirect Topics
Kappa opioid receptor signaling in the brain: Circuitry and implications for treatment - ScienceDirect
Buprenorphine: A Promising Yet Overlooked Tool (Page 3)
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion - ScienceDirect
Frontiers | Advances in Achieving Opioid Analgesia Without Side Effects | Pharmacology
Buprenorphine for Opioid Use Disorder: Mechanism of Action - Psychopharmacology Institute
Pharmaceuticals | Free Full-Text | Opioid Analgesia and Opioid-Induced Adverse Effects: A Review | HTML
Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: Current understanding and approaches to management - Pergolizzi - 2020 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Bias quantification at the kappa and mu opioid receptors. E-coupling... | Download Table
IJMS | Free Full-Text | The Mechanisms Involved in Morphine Addiction: An Overview | HTML
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain - The Journal of Pain
Kappa Opioid Receptors Drive a Tonic Aversive Component of Chronic Pain | Journal of Neuroscience
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor: Trends in Pharmacological Sciences
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back | Psychiatry
